Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
FLORIDA DEPARTMENT OF CORRECTIONS OFFICE OF HEALTH SERVICES TECHNICAL INSTRUCTION NO. 15.03.43 Page 1 of 7 SUBJECT: MANAGEMENT OF BLOODBORNE PATHOGEN EXPOSURES EFFECTIVE DATE: 9/10/02 I. PURPOSE: The purpose of this technical instruction (TI) is to assure that all employees and inmate patients who have had significant exposure to blood or other potentially infectious materials (OPIM) will be managed according to appropriate guidelines. II. III. DEFINITIONS: A. Significant exposure is defined in appendix A Bloodborne Pathogens (HBV, HCV, HIV—Significant Exposures and Risk of Infection. B. Bloodborne pathogens—For the purposes of this technical instruction, bloodborne pathogens are considered to include hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV). Other pathogens such as syphilis or the viruses of hemorrhagic fevers might also be present in blood or OPIM. GENERAL COMMENTS: A. Unless specified otherwise, instructions apply to employees and inmates. B. Institutional health services staff will a maintain packet of forms and steps for follow-up to provide guidance for the nurse on duty at the time that a bloodborne pathogen exposure occurs. The list of materials to be included in the packet are: 1. Detail of the steps to follow in assessing the exposed employee. 2. CDC appendix on postexposure drugs 3. Postexposure prophylaxis for bloodborne pathogens algorithm 4. DC4-798 Bloodborne Pathogens Exposure/Screening Incident Report (risk management form). 5. Emergency forms: a. b. DC4-701C Emergency Room Record DC4-708 Diagram of Injury TECHNICAL INSTRUCTION NO. 15.03.43 Page 2 of 7 SUBJECT: MANAGEMENT OF BLOODBORNE PATHOGEN EXPOSURES IV. 6. Form for refusal of follow-up care (DC4-792B Informed Consent [section B]) 7. Workers’ compensation paperwork/forms (for use with health services personnel exposures) C. An outline of the steps to be followed (brief checklist) will be posted in the emergency room (see appendix B Bloodborne Pathogen Exposure Brief Checklist). The complete description of steps (see appendix C Bloodborne Pathogen Exposure Checklist) to be taken based on this outline will be a part of the packet. D. If an injury is so severe that immediate transport is needed, the receiving institution will be notified that a bloodborne pathogens exposure is part of the injury. Documentation of the circumstances of this exposure will be completed on the same forms as any other bloodborne exposure. E. The supervisor of the exposed employee will complete the necessary workers’ compensation paperwork. F. The environmental health and safety officer (EHSO) will coordinate the process of workers’ compensation and bloodborne pathogen exposures. IMMEDIATE RESPONSE: A. B. The employee shall take first aid precautions as soon as possible. 1. Blood on skin areas should be washed off with soap and water. 2. Clothing splashed with blood: the clothing should be removed and other employees should be requested to assist with locating other clothing for the worker to wear. 3. Do NOT use chlorine bleach as an antiseptic in an attempt to kill HIV. It cannot kill virus that has already gotten into the blood stream and it will be damaging to skin. Attempts to squeeze out blood in an attempt to remove any virus are also not helpful if virus has entered the blood stream and has gotten beyond the local area already. Use the time to follow the remainder of this procedure and obtain the appropriate medical attention. The exposed employee will report the exposure incident to their supervisor as soon as possible. TECHNICAL INSTRUCTION NO. 15.03.43 Page 3 of 7 SUBJECT: MANAGEMENT OF BLOODBORNE PATHOGEN EXPOSURES V. VI. C. The supervisor will arrange for relief for the employee from job responsibilities as soon as possible. D. The exposed individual will be assessed in the institutional health services unit. EVALUATION OF EXPOSURES FOR SIGNIFICANCE: A. See appendix A Bloodborne Pathogens (HBV,HCV, HIV)—Significant Exposures and Risk of Infection and appendix C Bloodborne Pathogen Exposure Checklist. B. The evaluation will consider at least hepatitis B, hepatitis C, and HIV. Other bloodborne pathogens will be considered if there is reason to believe that those pathogens might be involved in the particular exposure at hand. C. If a physician is not present, the on-call physician will be contacted immediately and information about the exposure will be presented to him/her. If the institutional on-call physician cannot be reached, the Regional Medical Executive Director will be contacted for assistance. D. A decision will be made regarding immediate prophylactic medication and the exposed employee will be counseled regarding the benefits and risks of taking this medication. E. Employees will be referred to the workers’ compensation provider. The institutional environmental health and safety officer is responsible for coordination of this process. A toll-free telephone number is to be called to access the workers’ compensation provider and request permission to send the exposed employee to a site for medical follow-up. This toll-free number will be posted in the emergency room so that the nurse in charge will have access to it in a timely manner in the case of an exposure incident. F. If an exposed employee refuses follow-up for an exposure that is judged to be significant, the employee will be required to sign DC4-792B Informed Refusal. If an exposed inmate refuses follow-up for an exposure that is judged to be significant, the inmate will be required to sign DC4-711A Refusal of Health Care Services Affidavit. PROVISION OF MEDICATIONS IF NEEDED: A. All institutions will have a prepackaged zidovudine (AZT), Lamivudine (3TC), and Indinavir (IDV, Crixivan) available in the appropriate dosage made up and packaged by the institutional pharmacy. This will have an appropriate warning label indicating, at the least, that the medications contained within may cause nausea, vomiting, diarrhea, allergy, and/or other side effects. This medication is TECHNICAL INSTRUCTION NO. 15.03.43 Page 4 of 7 SUBJECT: MANAGEMENT OF BLOODBORNE PATHOGEN EXPOSURES to be taken only upon order of a physician. Its purpose is to reduce the chances of contracting a dangerous disease. 1. This dose pack is to be given by order of the contacted physician to any person who has had a significant exposure and desires prophylactic therapy. 2. This therapy is consistent with the most currently available information concerning the prophylaxis of HIV transmission. B. Before medication is given, the patient will be counseled concerning the reasons for the medication and the possible side effects. See information on the medications in appendix D HIV Postexposure Prophylaxis for Bloodborne Pathogens, appendix E HIV Postexposure Prophylaxis—Basic and Expanded Regimens, and DC4-792C Postexposure Prophylaxis HIV Counseling. C. An acknowledgment (DC4-792C) that this information was provided and the medication was initiated will be signed by the injured patient. If the patient declines to start medication this time, such shall be documented on the form. D. All institutions are authorized to administer this dose pack to employees, inmates, or others on an emergency basis. Medication should be given within two hours of exposure if at all possible. E. When an exposed employee demands preventive medication after a medical decision is made that the exposure does not meet the guidelines to offer this medication, further effort to educate the employee will be provided to explain the decision. The education fact sheet (see attachment) regarding this situation will be provided to the employee, and health care personnel will answer any questions. F. If a decision is made to give the initial dose of post exposure prophylactic medications the exposed employee must be sent to a Worker’s comp site for further evaluation. G. If for any reason the employee cannot be seen by the workers’ compensation provider or cannot obtain an ongoing supply of this prophylactic medication from a local pharmacy, the Department of Corrections will continue to supply the medication until the medication is available from the local pharmacy. 1. The medications in the pack are given on different schedules. The exposed person will need additional education to understand when to take each medication. TECHNICAL INSTRUCTION NO. 15.03.43 Page 5 of 7 SUBJECT: MANAGEMENT OF BLOODBORNE PATHOGEN EXPOSURES VII. 2. It is expected that the exposed person will be able to obtain medication within a few days. 3. Any delay will be reported to the Central Office Pharmacy Services Director. REPORTING OF BLOODBORNE PATHOGEN EXPOSURE: A. Telephone notification will be made to the Infection Control Coordinator or the Director of Nursing Services during business hours. During nonbusiness hours: the officer in charge will be notified who will then notify the Central Office Emergency Reporting Center who will in turn notify the on-call Central Office Health Services administrator to assure that the appropriate procedures have been initiated. B. Following a bloodborne pathogen exposure, an appropriate DC6-210 Incident Report will be completed. Other institutional forms will be completed as needed. VIII. INSTITUTIONS WITHOUT 24-HOUR MEDICAL COVERAGE: When medical personnel are present, bloodborne pathogens will be managed as directed in this TI. When medical personnel are not present, security staff will send the exposed person to a workers’ compensation provider as quickly as possible. If there are any questions for medical personnel, the officer in charge will contact the responsible major institution. Information about the incident will be provided to medical personnel at the earliest possible time after the exposure occurs. Medical personnel will ensure that the appropriate security personnel know the procedure concerning follow-up for bloodborne pathogen exposures. IX. HEPATITIS B VACCINATION: A. All departmental employees will be assessed for risk of exposure to blood and other potentially infectious materials by reason of their job functions. See Bloodborne Pathogens Exposure Control Plan (or appropriate departmental document) for the list of at-risk job functions. This list is determined based on duties involved in the job and the possibility of exposure to blood or other potentially infectious materials B. Information about vaccine will be provided in the department and health care employee education and in written form using the Centers for Disease Control and TECHNICAL INSTRUCTION NO. 15.03.43 Page 6 of 7 SUBJECT: MANAGEMENT OF BLOODBORNE PATHOGEN EXPOSURES Prevention vaccine information statement for hepatitis B. This will be provided in department education programs that will precede the vaccination program. X. C. These employees at risk will be offered hepatitis B vaccine according to the departmental exposure control plan. Consent for vaccination will be completed using DC4-792A Hepatitis B Vaccine Informed Consent/Previous Vaccination Documentation. D. Employees who have previously been vaccinated against hepatitis B may decline vaccination using the same form (DC4-792A). E. Employees may refuse hepatitis B vaccine. The refusal will be documented on DC4-792B Informed Refusal, section A. The employee may rescind this refusal at any time and start the hepatitis vaccine series. F. Inmates who perform job functions that put them at risk of exposure to blood or OPIM, will be provided bloodborne pathogens education and provided the opportunity to receive hepatitis B vaccination. Consent for vaccination will be recorded on DC4-710C Immunization Record Card and refusal of vaccination will be documented on DC4-792B section A HEALTH CARE EMPLOYEE EDUCATION: A. All Health Service employees will receive education on bloodborne pathogens upon employment and on an annual basis. B. All topics, as listed in the OSHA standard 29 CFR Part 1910 Occupational Exposure to Bloodborne Pathogens; Needlesticks and Other Sharps Injuries, will be covered. C. A curriculum is attached to this TI (see appendix F—Bloodborne Pathogens for Health Care Workers Curriculum). D. Reference materials will be provided to each institution by the Central Office Infection Control Coordinator. Updated information will also be provided by the Central Office Infection Control Coordinator to every institution for use in the annual education program. TECHNICAL INSTRUCTION NO. 15.03.43 Page 7 of 7 SUBJECT: MANAGEMENT OF BLOODBORNE PATHOGEN EXPOSURES XI. REFERENCES: A. B. C. XII. Departmental Exposure Control Plan Florida Department of Corrections Safety Manual Departmental procedure Management of Bloodborne Pathogen Exposures (to be issued) IMPLEMENTATION DATE: Each institution will implement this technical instruction no later than 30 days after signature. Director of Health Services Date Attachment: Education Fact Sheet Appendix A Bloodborne Pathogens (HBV,HCV, HIV)—Significant Exposures and Risk of Infection Appendix B Bloodborne Pathogen Exposure Brief Checklist Appendix C Bloodborne Pathogen Exposure Checklist Appendix D HIV Postexposure Prophylaxis for Bloodborne Pathogens Appendix E HIV Postexposure Prophylaxis—Basic and Expanded Regimens Appendix F Bloodborne Pathogens for Health Care Workers Curriculum Section I Bloodborne Infections Section II Transmission Section III Exposure Control Section IV Work Practice Controls Section V Postexposure Prophylaxis This Technical Instruction Supersedes: Section VIII of TI 15.03.22 dated 4/19/01